胸膜腔内注入尿激酶对结核性胸膜炎疗效的影响

目的：观察胸膜腔内注入尿激酶对结核性胸膜炎疗效的影响。方法：随机抽取住院病人76例，分为尿激酶治疗组和对照组．治疗组在全身化疗的基础上。将尿激酶注入胸膜腔。结果：胸水吸收治愈率，治疗组82.4％，对照组50．0％；胸水10天以内吸收者，治疗组47．1％，对照组14.3％；胸膜增厚，治疗组17．6％，对照组45．2％。结论：尿激酶胸膜腔内注入疗法，可以缩短结核性渗出性胸膜炎胸水吸收时间及减少胸膜增厚后遗症，有较大的临床应用价值。

Effect of intrapleural injection of urokinase on the curative effect of tuberculous pleuritis

Objective:To study the effect of intrapleural injection of urokinase on the curative effect of tuberculous pleuritis.Methods:Cases were randomly divided into treatment group and control group. Pleural cavities of cases in treatment group were given urokinase on the basis of chemical treatment.Results:There was significant difference in the curative effect between the two groups.The cure rate of hydrothorax absorption in treatment group was 82.4%,and that in control group was 50.0%. Hydrothorax of 47.1% cases in treatment group was absorbed completely within 10 days and hydrothorax of 14.3% cases in control group was absorbed completely in the same period.Pachynsis:pleurae of treatment group was 17.6% and that of control group was 45.2%. Conclusion:The way by intrapleural injecti of urokinase could short hydrothorax absorption time of tuberculous pleuritis and reduce pachynsis paeurae.It is higher appliea value to treat tuberculosis pleuritis.